Abbott reports Q2 Worldwide Medical Devices sales up 10.2% on reported basis

In Q2, Worldwide Medical Devices sales increased 10.2% on a reported basis and 12.1% on an organic basis in the second quarter, including double-digit organic growth in both the U.S. and internationally. Sales growth was led by double-digit growth in Diabetes Care, Electrophysiology, and Structural Heart. Several recently launched products and new indications contributed to the strong performance, including Amplatzer, Amulet, Navitor, TriClip, and AVEIR. In Electrophysiology, sales grew 13.3% on a reported basis and 16.7% on an organic basis, which included double-digit growth in catheters and cardiac mapping-related products, and double-digit growth in all major geographic regions. In Diabetes Care, FreeStyle Libre sales were $1.6B, which represents sales growth of 18.4% on a reported basis and 20.4% on an organic basis.